Anna Andrzejczak

Wroclaw, DS, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cardiometabolic disease risk: the joint role of the UCP1, UCP2, UCP3, and FTO gene variants.

Cardiometabolic disease risk: the joint role of the UCP1, UCP2, UCP3, and FTO gene variants.

Journal: Biochimie

Published: June 07, 2026

Dynamic translocation of Inside-Out proteins to the cell surface underlies cellular adaptation to cancer-induced stress.

Dynamic translocation of Inside-Out proteins to the cell surface underlies cellular adaptation to cancer-induced stress.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 24, 2026

Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome.

Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome.

Journal: Human immunology

Published: January 12, 2026

A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.

A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.

Journal: Frontiers in immunology

Published: September 23, 2025

Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.

Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.

Journal: Biomarker research

Published: September 19, 2025

miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy.

miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy.

Journal: Biomolecules

Published: August 29, 2025

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.

Journal: International journal of molecular sciences

Published: May 28, 2024

BTLA biology in cancer: from bench discoveries to clinical potentials.

BTLA biology in cancer: from bench discoveries to clinical potentials.

Journal: Biomarker research

Published: September 08, 2023

Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.

Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.

Journal: Journal of cancer research and clinical oncology

Published: December 21, 2022

NGS Sequencing Reveals New UCP1 Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population-A Preliminary Study.

NGS Sequencing Reveals New UCP1 Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population-A Preliminary Study.

Journal: Genes

Published: December 19, 2022

The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis.

The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis.

Journal: International journal of molecular sciences

Published: November 29, 2022

The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers.

The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers.

Journal: Frontiers in immunology

Published: July 29, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026